-
1
-
2دورية أكاديمية
-
3
-
4دورية أكاديمية
الإتاحة: https://doi.org/10.6084/m9.figshare.25844374.v110.6084/m9.figshare.2584437410.3322/caac.2166010.1016/j.annonc.2021.02.01510.1038/s41573-020-0076-610.1056/nejmoa110553510.1016/s1470-2045Test(17)30469-210.1016/j.ygyno.2021.12.02510.1158/1078-0432.ccr-21-302310.1158/2159-8290.cd-18-121810.1158/1078-0432.ccr-16-321510.1038/s41467-022-28389-310.1038/nrc.2017.710.1200/jco.2016.70.462710.1038/gim.2015.3010.1038/s41571-021-00473-510.1016/j.jtho.2016.11.222810.3389/fonc.2021.74657110.1038/s41698-023-00402-y10.1038/nature1016610.1016/s1470-2045(16)30559-9
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Exploratory_biomarker_analysis_in_the_phase_III_L-MOCA_study_of_olaparib_maintenance_therapy_in_patients_with_platinum-sensitive_relapsed_ovarian_cancer/25844374/1Test -
5
-
6
-
7دورية أكاديميةClinical research in ovarian cancer:consensus recommendations from the Gynecologic Cancer InterGroup
الإتاحة: https://doi.org/10.1016/S1470-2045Test(22)00139-5
https://pure.eur.nl/en/publications/8eea48d9-43a2-49b9-a0f6-4517d8cf45a4Test
https://pure.eur.nl/ws/files/94841288/complete.pdfTest
http://www.scopus.com/inward/record.url?scp=85135243543&partnerID=8YFLogxKTest -
8
-
9
-
10